Features

The 2011 IPAC-RS conference, held in Rockville, MD March 29-31, featured speakers from a number of FDA offices discussing the agency’s efforts relevant to orally inhaled and nasal drug products (OINDPs). Among those speakers was Ronald Kaye, Human Factors Pre-Market Evaluation Team Leader from the Office of Device Evaluation in the Center for Devices and Radiological … [Read more...] about Another FDA group seeks to review OINDPs

Speakers representing the FDA and several IPAC-RS working groups dominated day 2 of the 2011 IPAC-RS conference, with presentations and panel discussions on the day's main topic, "Product Quality." The day began with the keynote address delivered by Prasad Peri of the FDA's Office of New Drug Quality Assessment and concluded with the announcement of the poster … [Read more...] about IPAC-RS conference — Day 2

Day 1 of the 2011 IPAC-RS conference featured 13 talks and a panel discussion, covering two topics aligned with the conference theme of "Bring Value to the Patient in a Changing World." The morning focus, "Voice of the Customers," included presentations by clinicians, a patient education specialist, and the FDA Office of Special Health Issues, in addition to a report … [Read more...] about IPAC-RS conference — Day 1

On March 31, 2011, 150-200 prospective buyers will gather in a Beaux Arts ballroom in New York City for ICAP Ocean Tomo's Spring 2011 Live Auction. After having attended a welcome dinner the previous night featuring keynote speaker Malcolm Gladwell, the attendees will get down to the business of buying intellectual property amid the Corinthian columns and marble … [Read more...] about Inhalation IP up for sale at live auction

Numerous studies have described the difficulties patients experience in using metered dose inhalers (MDIs), including a recent article in the Journal of General Internal Medicine (JGIM) that found 86% of hospitalized patients enrolled in a study unable to properly complete at least 75% of the steps necessary for effective use of an MDI. As with many such … [Read more...] about Can patients learn to use MDIs?

On the second day of the Drug Delivery to the Lungs meeting in December 2010 (DDL 21), Xiang Kou, a grad student from the National University of Singapore who had been spending time as a visiting scholar at Purdue University, was approaching the end of his presentation on “Direct observation of particle dispersion mechanisms in DPI using particle image … [Read more...] about Young OINDP researchers on the job hunt

The Impactor Sub-Team of the European Pharmaceutical Aerosol Group (EPAG), a consortium of pharmaceutical companies that develop pulmonary and intranasal drugs, has focused its attention on the potential benefits of the abbreviated impactor method (AIM), a fast screening technique  to provide a good estimate of the potentially respirable and non-respirable … [Read more...] about An update on EPAG activities related to the Abbreviated Impactor Method (AIM)

At the next IPAC-RS conference, March 29-31 in Rockville, MD, sponsored by the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS), OINDP specialists will have uncommon opportunities to interact with regulators, representatives of patient organizations, and clinicians. The meeting, titled “Bringing Value to the Patient in a … [Read more...] about The upcoming IPAC-RS conference features updates from FDA representatives

On Friday, December 10, just as the snow was beginning to melt in Edinburgh, DDL 21 concluded with one last podium session. Delegates also had a chance to spend some additional time at the exhibition. The day began with a talk by Karen Pickering, MBE, a 4-time Olympic swimmer, winner of 4 Commonwealth Games gold medals, and an ambassador for Asthma UK. Pickering … [Read more...] about DDL 21 — Day 3